Pregled bibliografske jedinice broj: 1156489
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness // Cancers, 13 (2021), 20; 5231, 25 doi:10.3390/cancers13205231 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1156489 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Altered Expression of Shorter p53 Family Isoforms
Can Impact Melanoma Aggressiveness
Autori
Tadijan, Ana ; Precazzini, Francesca ; Hanžić, Nikolina ; Radić, Martina ; Gavioli, Nicolò ; Vlašić, Ignacija ; Ozretić, Petar ; Pinto, Lia ; Škreblin, Lidija ; Barban, Giulia ; Slade, Neda ; Ciribilli, Yari
Izvornik
Cancers (2072-6694) 13
(2021), 20;
5231, 25
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
melanoma ; p53 ; p73 ; Δ160p53 ; isoforms ; targeted therapy ; resistance
Sažetak
Cutaneous melanoma is the most aggressive form of skin cancer. Despite the significant advances in the management of melanoma in recent decades, it still represents a challenge for clinicians. The TP53 gene, the guardian of the genome, which is altered in more than 50% of human cancers, is rarely mutated in melanoma. More recently, researchers started to appreciate the importance of shorter p53 isoforms as potential modifiers of the p53-dependent responses. We analyzed the expression of p53 and p73 isoforms both at the RNA and protein level in a panel of melanoma-derived cell lines with different TP53 and BRAF status, in normal conditions or upon treatment with common anti-cancer DNA damaging agents or targeted therapy. Using lentiviral vectors, we also generated stable clones of H1299 p53 null cells over-expressing the less characterized isoforms Δ160p53α, Δ160p53β, and Δ160p53γ. Further, we obtained two melanoma-derived cell lines resistant to BRAF inhibitor vemurafenib. We observed that melanoma cell lines expressed a wide array of p53 and p73 isoforms, with Δ160p53α as the most variable one. We demonstrated for the first time that Δ160p53α, and to a lesser extent Δ160p53β, can be recruited on chromatin, and that Δ160p53γ can localize in perinuclear foci ; moreover, all Δ160p53 isoforms can stimulate proliferation and in vitro migration. Lastly, vemurafenib-resistant melanoma cells showed an altered expression of p53 and p73 isoforms, namely an increased expression of potentially pro-oncogenic Δ40p53β and a decrease in tumor-suppressive TAp73β. We therefore propose that p53 family isoforms can play a role in melanoma cells’ aggressiveness.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2013-11-1615 - Otkrivanje novih proteinskih interakcija kao podloga za nove pristupe liječenju melanoma čovjeka (ProNetMel) (Slade, Neda, HRZZ - 2013-11) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Hrvatski zavod za transfuzijsku medicinu
Profili:
Ana Tadijan
(autor)
Martina Radić
(autor)
Neda Slade
(autor)
Nikolina Hanžić
(autor)
Ignacija Vlašić
(autor)
Petar Ozretić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus